TREAT - 医索

找到约 157 条结果

A Multinational Pivotal Study of Sunvozertinib inPlatinum Pre-treated Non-Small Cell Lung Cancerwith EGFR Exon 20 Insertion MutationsPrimary Analysis of WU-KONG1 Study

医客学院 - 会议报告集

Total neoadjuvant treatment with long-course radiotherapyversus concurrent chemoradiotherapy in local advanced rectalcancer with high risk factors (TNTCRT)A multicenter,randomized, open-label, phase

医客学院 - 会议报告集

Phase l trial of hypoxia-responsive CEA CAR-T celltherapy in patients with heavily pretreated solid tumorvia intraperitoneal or intravenous transfusion

医客学院 - 会议报告集

Nivolumab plus ipilimumab vs chemotherapy as first-linetreatment for microsatellite instability-highmismatchrepairdeficient metastatic colorectal cancer expandedefficacy analysis from CheckMate 8HW

医客学院 - 会议报告集

Neoadjuvant treatment of lBl310 (anti-CTLA-4 antibody) plus sintilimab(anti-PD.1 antibody) in patients with microsatellite instabilityhighmismatchrepair-deficient colon cancer Results from a randomiz

医客学院 - 会议报告集

ARC-9 A Randomized Study to EvaluateEtrumadenant Based freatmentCombinations in Previously TreatedMetastatic Colorectal Cancer

医客学院 - 会议报告集

吴一龙教授：肺癌适应性治疗的加加减减，MRD未来是重要的指导思路（内附下载）

关注医微客公众号，对话框回复关键词【肺癌治疗】，获取《Adaptive treatment：肺癌治疗的加加减减》PDF原文件近期，吴一龙教授在《循证医学》杂志上谈论了：Adaptive treatment：肺癌治疗的加加减减。我们看到了其定义：“adaptive trea.....

学术资讯 - 百宝箱资讯

吴一龙：Adaptivetreatment：肺癌治疗的加加减减

医客学院 - 其他

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma A Phase 3 Randomized Clinical Trial

医客学院 - 药物研究

Study EV-103 Cohort H_Antitumor activity of neoadjuvant treatment with enfortumab vedotin monotherapy in patients with MIBC who are cisplatin-ineligible

医客学院 - 会议报告集

今日实时热搜